Vyome corrected pro forma statements show combined net loss $522k, revenue $249k for H1 2025

Vyome Holdings, Inc

Corrected pro forma for H1 2025: combined net loss $522k, revenue $249k, EPS $(0.07).
Vyome shareholders to own 92.4% of combined company on fully-diluted basis post-merger.
Asset sale to Biorad for $1.6M in cash; concurrent financing totals $7.3M, including $660k bridge notes.
Pro forma weighted-average shares of 7,191,409; combined total assets $6.95M, equity $4.79M.
Merger closed August 14, 2025; filing corrects previously erroneous pro forma calculations.

item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.